Tyler Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tyler Long has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Aaron Burch
Edward Via College of Osteopathic Medicine, Auburn, Alabama
1 shared publicationAkhil Gupta
Advanced Dermatology & Cosmetic Surgery, Margate, Florida
1 shared publicationBrian Bonomo
Suncoast Dermatology
1 shared publicationCraig Garofola
Department of Dermatology, LewisGale Hospital Montgomery, Blacksburg, Virginia
1 shared publicationGeorge Gibbons
Medical Director—Dermpath Diagnostics Bay Area of Dermatopathology
1 shared publicationRalph Massullo
Suncoast Dermatology
1 shared publication
Latest Publications
- 1 December 2023
- Published by Frontline Medical Communications, Inc. in Cutis
- Vol. 112 (6) , E6-E11
The Role of Toluidine Blue in Mohs Micrographic Surgery: A Systematic Review
Toluidine blue (TB), a dye with metachromatic staining properties, was developed in 1856 by William Henry Perkin.1 Metachromasia is a perceptible change in the
- 1 December 2023
- Published by Frontline Medical Communications, Inc. in Cutis
- Vol. 112 (6) , E6-E11
The Role of Toluidine Blue in Mohs Micrographic Surgery: A Systematic Review
Toluidine blue (TB), a dye with metachromatic staining properties, was developed in 1856 by William Henry Perkin.1 Metachromasia is a perceptible change in the
- Open Access
- 20 August 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 28, 136-137
Linear Darier disease after COVID-19 infection
- 20 August 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 28, 136-137
Open AccessLinear Darier disease after COVID-19 infection
- 15 February 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (4) , 836-844
Platelet‐rich plasma in noninvasive procedures for atrophic acne scars: A systematic review and meta‐analysis
Background: The use of platelet‐rich plasma (PRP) combined with noninvasive, nonenergy procedures for atrophic acne scars has shown promise. To date, there has not been a systematic review or meta‐analysis of the effectiveness of this therapy.Aims: To use meta‐analysis to compare Goodman and Baron qualitative scores, patient satisfaction outcomes, and adverse effects in patients undergoing combination procedures with PRP, combination procedures without PRP, and noninvasive monotherapy without PRP in the treatment of patients with atrophic acne scars.Patients/Methods: The Pubmed and Cochrane library databases were searched for relevant studies published before May 1, 2019. PRISMA guidelines were utilized. Studies that compared the use of PRP in combination with a noninvasive procedure and therapies without PRP for the treatment of atrophic acne scars were included. Cochrane's handbook was utilized to assess the individual biases of the included studies. Publication bias was assessed.Results: A total of 311 participants (153 whole‐face participants and 158 split‐face participants) were reviewed across eight included studies. Quantitative analysis of 241 participants across six included studies showed a statistically significant reduction in scar severity scores in favor of microneedling or subcision with PRP (P < .001). Combination therapy with intradermal or topical PRP was significantly more effective than monotherapy alone and combination therapy with an adjunct other than PRP (P < .001 and .001, respectively).Conclusion: This systematic review and meta‐analysis demonstrated that microneedling or subcision with PRP produced statistically significant improvement in validated outcomes over microneedling or subcision alone.
- 15 February 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (4) , 836-844
Platelet‐rich plasma in noninvasive procedures for atrophic acne scars: A systematic review and meta‐analysis
Background: The use of platelet‐rich plasma (PRP) combined with noninvasive, nonenergy procedures for atrophic acne scars has shown promise. To date, there has not been a systematic review or meta‐analysis of the effectiveness of this therapy.Aims: To use meta‐analysis to compare Goodman and Baron qualitative scores, patient satisfaction outcomes, and adverse effects in patients undergoing combination procedures with PRP, combination procedures without PRP, and noninvasive monotherapy without PRP in the treatment of patients with atrophic acne scars.Patients/Methods: The Pubmed and Cochrane library databases were searched for relevant studies published before May 1, 2019. PRISMA guidelines were utilized. Studies that compared the use of PRP in combination with a noninvasive procedure and therapies without PRP for the treatment of atrophic acne scars were included. Cochrane's handbook was utilized to assess the individual biases of the included studies. Publication bias was assessed.Results: A total of 311 participants (153 whole‐face participants and 158 split‐face participants) were reviewed across eight included studies. Quantitative analysis of 241 participants across six included studies showed a statistically significant reduction in scar severity scores in favor of microneedling or subcision with PRP (P < .001). Combination therapy with intradermal or topical PRP was significantly more effective than monotherapy alone and combination therapy with an adjunct other than PRP (P < .001 and .001, respectively).Conclusion: This systematic review and meta‐analysis demonstrated that microneedling or subcision with PRP produced statistically significant improvement in validated outcomes over microneedling or subcision alone.
- Open Access
- 22 October 2019
- Published by Hindawi Limited in Case Reports in Pathology
- Vol. 2019, 1-3
Is Syringocystadenoma Papilliferum Incidental in This Verrucous Carcinoma?
This case report presents a case in which a collision tumor consisting of three separate pathological entities—a verrucous carcinoma (VC), syringocystadenoma papilliferum (SCAP), and a basal cell carcinoma (BCC). The presentation of this collision tumor is unexpected. It presented as an exophytic mass on the scalp. While collisions of SCAP and VC are present in the literature, this case included an additional pathologic entity. The association of these entities and the unreported location of the lesion may provide some further insight as to the etiology of VC.
- 22 October 2019
- Published by Hindawi Limited in Case Reports in Pathology
- Vol. 2019, 1-3
Open AccessIs Syringocystadenoma Papilliferum Incidental in This Verrucous Carcinoma?
This case report presents a case in which a collision tumor consisting of three separate pathological entities—a verrucous carcinoma (VC), syringocystadenoma papilliferum (SCAP), and a basal cell carcinoma (BCC). The presentation of this collision tumor is unexpected. It presented as an exophytic mass on the scalp. While collisions of SCAP and VC are present in the literature, this case included an additional pathologic entity. The association of these entities and the unreported location of the lesion may provide some further insight as to the etiology of VC.